Events Partner Content 4th RAS-Targeted Drug Development Summit For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible.
Events Partner Content Targeted Radiopharmaceuticals Summit US (TRP US) The inaugural Targeted Radiopharmaceuticals Summit US will bring together a worldwide community of specialists to address long-standing challenges in radiopharmac
Events Partner Content TCR-based Therapeutics for Solid Tumors Summit Hear from experts at the TCR based Therapeutics Summit
Events Partner Content Welcome to the 2nd Tumor Myeloid-Directed Therapies Summit Identify, Validate, & Clinically Develop Novel Targets to Modulate Myeloid Cells & Overcome Solid Tumor Barriers
News Biliary tract cancer drug granted orphan drug designation in... The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
